Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents
Condition(s) studied
Investigational drug(s) / intervention(s)
Isoflurane Inhalant Product: Isoflurane will be administered using an inhalation device
Study summary
The goal of a pilot study is to test a study plan to see if it is appropriate for a larger study. This study plan is looking at whether the use of inhaled sedatives (medications that help people be calm and sleep) can reduce delirium (extreme confusion) in children who need a ventilator (breathing machine) compared to IV or oral sedatives.
The main question\[s\] it aims to answer are:
* Will people join the study? (recruitment)
* Will participants finish the study?
* Will healthcare teams accept the study procedures?
Participants will be randomized to receive study treatment (inhaled sedation) or standard of care (IV sedation). They will be monitored daily for up to 28 days. They will complete memory, thinking and behaviour tasks after 9-12 months.
Eligibility
Primary outcome measure(s)
- Participant recruitment — 2 years
Accrual and/or identification of challenges in accruing 60 mechanically ventilated participants (age 1 month to 18 years).
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| McMaster Children's Hospital | Hamilton | Ontario | Recruiting |
| Children's Hospital - London Health Sciences Centre | London | Ontario | Recruiting |
| The Hospital for Sick Children (SickKids) | Toronto | Ontario | Recruiting |
More Sunnybrook Health Sciences Centre trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05867472 on ClinicalTrials.gov ↗ ← All trials in Canada